News Hub

Real-time financial, economic, and global news with market-focused context and analysis.

Coverage spans equities, macroeconomic data, commodities, currencies, technology, politics, and global events—paired with analysis that highlights why each development matters for traders and investors. From breaking headlines to hourly market snapshots and in-depth articles, the News Hub is designed to help you stay informed, oriented, and ahead of market-moving events.

  • Royal Caribbean beat earnings and raised EPS guidance but trimmed revenue outlook; stock pullback created a dip-buy setup near $312.
  • Analysts pitch Netflix as an actionable long with a $94.50 target, citing profitable growth and operating leverage.
  • Broadcom is presented as a lower-volatility AI-hardware play, backed by strong free cash flow and enterprise software revenue.
  • MicroCloud Hologram (HOLO) launched DSQ-Net, a hybrid quantum-classical spiking neural network for noisy image classification.
  • TOP Financial (TOP) approved a 1-for-5 share consolidation effective August 3, 2026; shares will keep the same ticker.
  • K Wave Media (KWM) will implement a 1-for-30 reverse split on August 3, 2026 to meet Nasdaq price rules.

Latest Articles

Cognition Therapeutics Receives Second Philanthropic Donation to Extend Ongoing Expanded Access Program for Zervimesine (CT1812) in Dementia with Lewy Bodies

Cognition Therapeutics Receives Second Philanthropic Donation to Extend Ongoing Expanded Access Program for Zervimesine (CT1812) in Dementia with Lewy Bodies

Cognition Therapeutics announced receipt of a second philanthropic donation that allows the continuation of its expanded access program (EAP) providing Zervimesine (CT1812) treatment to patients with Dementia with Lewy Bodies (DLB). The EAP, launched in 2025 and currently serving 32 participants, is now extended to two years of treatment. Positive …

Milestone Scientific Reports Financial Results for First Quarter 2026

Milestone Scientific Reports Financial Results for First Quarter 2026

Milestone Scientific Inc. announced its Q1 2026 financial results showing a 30% reduction in operating expenses, significantly narrowed operating loss, and stable revenue despite Middle East shipping challenges. Medical segment revenues more than doubled year-over-year. The company completed a $2.15 million financing in April 2026 to support growth…

MiNK Therapeutics and First Lviv Territorial Medical Union Initiate Randomized Phase 2 Trial of agenT-797 in Acute Lung Injury and Critical Illness

MiNK Therapeutics and First Lviv Territorial Medical Union Initiate Randomized Phase 2 Trial of agenT-797 in Acute Lung Injury and Critical Illness

MiNK Therapeutics has initiated a randomized Phase 2 clinical trial evaluating their off-the-shelf allogeneic invariant natural killer T (iNKT) cell therapy, agenT-797, in patients with severe acute lung injury (ALI) and acute respiratory distress syndrome (ARDS). The study, conducted in partnership with First Lviv Territorial Medical Union and sup…

HCW Biologics Discovers that HCW11-040 Prevents Bronchopulmonary Dysplasia (BPD) During IND-Enabling Studies

HCW Biologics Discovers that HCW11-040 Prevents Bronchopulmonary Dysplasia (BPD) During IND-Enabling Studies

HCW Biologics announced that its immunotherapeutic candidate HCW11-040, a pembrolizumab-based fusion protein, successfully prevented bronchopulmonary dysplasia (BPD) in an animal model during IND-enabling studies. The company plans to complete these studies by late 2027 and file an IND application promptly to treat infants at high risk of BPD, a ra…

Genie Energy Announces First Quarter 2026 Results

Genie Energy Announces First Quarter 2026 Results

Genie Energy Ltd. announced its Q1 2026 financial results showing record revenue growth to $142.3 million but significant declines in gross profit, operating income, and adjusted EBITDA due to margin compression and higher customer acquisition costs. The company lowered its full-year 2026 adjusted EBITDA guidance citing ongoing margin pressures and…

Fiserv Forms Strategic Collaboration with OpenAI to Bring AI to How Fiserv Serves Financial Institutions

Fiserv Forms Strategic Collaboration with OpenAI to Bring AI to How Fiserv Serves Financial Institutions

Fiserv, a leading financial technology company, has announced a strategic collaboration with OpenAI to incorporate frontier AI technologies into its platforms serving financial institutions. The partnership focuses on building strategic AI agents, accelerating banking modernization efforts, developing banking-specific AI capabilities, and enhancing…

Celcuity’s Phase 3 VIKTORIA-2 Trial of Gedatolisib as a First-Line Treatment for HR+/HER2- Advanced Breast Cancer Expanding to Include Endocrine-Sensitive Patients

Celcuity’s Phase 3 VIKTORIA-2 Trial of Gedatolisib as a First-Line Treatment for HR+/HER2- Advanced Breast Cancer Expanding to Include Endocrine-Sensitive Patients

Celcuity Inc., a clinical-stage biotech company, announced an expansion of its Phase 3 VIKTORIA-2 study evaluating gedatolisib for HR+/HER2- advanced breast cancer to now include endocrine-sensitive patients, alongside endocrine-resistant ones. The company also submitted a patent application for a subcutaneous version of gedatolisib to improve long…

FitLife Brands Announces First Quarter 2026 Results

FitLife Brands Announces First Quarter 2026 Results

FitLife Brands, Inc. announced first quarter 2026 financial results with total revenue rising 59% year-over-year to $25.3 million, fueled primarily by the acquisition of Irwin which contributed significantly to wholesale revenue growth. However, gross margin declined to 37.6% due to lower-margin Irwin business, and net income decreased to $1.7 mill…

Merlin, Inc. Reports First Quarter 2026 Results

Merlin, Inc. Reports First Quarter 2026 Results

Merlin, Inc., an aerospace and defense technology company specializing in autonomous flight systems, reported its Q1 2026 financials following its recent public listing. Key developments include successful automated takeoffs, advancement in civil certification with FAA and New Zealand CAA, progress on a $105 million military contract for C-130J aut…

FTI Consulting Survey: Majority of U.S. Hospital Leaders Predict Serious Financial Challenges in the Near Future

FTI Consulting Survey: Majority of U.S. Hospital Leaders Predict Serious Financial Challenges in the Near Future

FTI Consulting's 2026 Hospital Operations Outlook Survey reveals that 92% of US hospital leaders anticipate significant financial challenges ahead due to affordability, policy shifts, and evolving care delivery models. Key operational pressures include workforce shortages, physician recruitment difficulties, and data security concerns. Despite adva…

Nuvectis Pharma, Inc. To Participate in the H.C. Wainwright 4th Annual BioConnect Investor Conference at NASDAQ

Nuvectis Pharma, Inc. To Participate in the H.C. Wainwright 4th Annual BioConnect Investor Conference at NASDAQ

Nuvectis Pharma, a clinical-stage biopharmaceutical company developing precision oncology medicines, announced its participation in the H.C. Wainwright 4th Annual BioConnect Investor Conference on May 19, 2026. The company will present its clinical-stage drug candidate NXP900, which is targeting SRC family kinases for cancer treatment, with Phase 1…

Forgent Power Shares Jump After Massive Q3 Revenue Beat and Raised Guidance

Forgent Power Shares Jump After Massive Q3 Revenue Beat and Raised Guidance

Forgent Power Solutions climbed roughly 20% in pre-market trading after reporting fiscal Q3 2026 revenue of $379 million, more than double the $186 million recorded a year earlier, and raising full-year revenue guidance to $1.35 billion-$1.39 billion. Management's revised midpoint of $1.37 billion topped prior analyst consensus, and the company now…

Precigen Shares Jump as PAPZIMEOS Drives Transformational Revenue Beat

Precigen Shares Jump as PAPZIMEOS Drives Transformational Revenue Beat

Precigen surged in pre-market trading following a first-quarter 2026 report that far exceeded expectations, driven primarily by PAPZIMEOS sales. Revenue rose to $23.3 million versus $1.3 million a year earlier, with PAPZIMEOS contributing $21.6 million. The company narrowed its net loss to $7.9 million and signaled confidence in reaching cash flow …

U.S. and China Agree on AI Best-Practices Framework as Trump Meets Xi in Beijing

U.S. and China Agree on AI Best-Practices Framework as Trump Meets Xi in Beijing

The United States and China announced a protocol setting out best practices for artificial intelligence as President Donald Trump met Chinese President Xi Jinping in Beijing for a two-day summit. U.S. Treasury Secretary Scott Bessent said Washington is able to have substantive AI discussions with Beijing because the United States is ahead in AI cap…

Intuitive Machines to Acquire Goonhilly Earth Station and COMSAT

Intuitive Machines to Acquire Goonhilly Earth Station and COMSAT

Intuitive Machines, Inc. announced its definitive agreement to acquire Goonhilly Earth Station Ltd and its US-based COMSAT division. This acquisition is set to significantly enhance Intuitive Machines' integrated space-to-Earth communications network by adding 44 antennas and expanding capacity for deep space communications, data relay, and Positio…

Canadian Solar Shares Drop After Q1 Beat Fueled by One-Time Tariff Refund

Canadian Solar Shares Drop After Q1 Beat Fueled by One-Time Tariff Refund

Canadian Solar Inc. shares tumbled in pre-market trading after the company reported Q1 2026 results that included a one-off $93 million IEEPA tariff refund. While headline metrics showed a beat, management warned of significantly lower gross margins for Q2 and announced a CEO transition, amplifying investor concern about near-term profitability.

Buy the $500 Break: Mastercard Looks Like a Long-Term Setup

Buy the $500 Break: Mastercard Looks Like a Long-Term Setup

Mastercard's shares slipped below $500 after a recent pullback, but the company's cash generation, strong margins and durable network economics make this an attractive long-term trade. Enter at $492.00, stop at $470.00, target $560.00 over a 180 trading-day horizon; risk/reward and catalysts favor holding through macro noise while watching regulato…